Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar KimLanners (< 20) Submitted: 4/24/2011 2:12:26 AM : Outperform Start Price: $2.11 BPAX Score: -74.25

nanotech with solide technicals

Report this Post Reply

Featured Broker Partners


Advertisement